Explore the Potential with AI-Driven Innovation
This comprehensive focused library is produced on demand with state-of-the-art virtual screening and parameter assessment technology driven by Receptor.AI drug discovery platform. This approach outperforms traditional methods and provides higher-quality compounds with superior activity, selectivity and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our top-notch dedicated system is used to design specialised libraries.
Fig. 1. The sreening workflow of Receptor.AI
Utilising molecular simulations, our approach thoroughly examines a wide array of proteins, tracking their conformational changes individually and within complexes. Ensemble virtual screening enables us to address conformational flexibility, revealing essential binding sites at functional regions and allosteric locations. Our rigorous analysis guarantees that no potential mechanism of action is overlooked, aiming to uncover new therapeutic targets and lead compounds across diverse biological functions.
Our library stands out due to several important features:
partner
Reaxense
upacc
Q15843
UPID:
NEDD8_HUMAN
Alternative names:
Neddylin; Neural precursor cell expressed developmentally down-regulated protein 8; Ubiquitin-like protein Nedd8
Alternative UPACC:
Q15843; Q3SXN8; Q6LES6
Background:
NEDD8, known as Neddylin, Neural precursor cell expressed developmentally down-regulated protein 8, or Ubiquitin-like protein Nedd8, plays a pivotal role in cell cycle control and embryogenesis. It functions through its conjugation to a select group of cellular proteins, such as cullins and p53/TP53, facilitating crucial processes like polyubiquitination and proteasomal degradation of regulatory proteins. This ubiquitin-like protein's attachment to cullins is essential for the recruitment of E2 to the cullin-RING-based E3 ubiquitin-protein ligase complex.
Therapeutic significance:
Understanding the role of NEDD8 could open doors to potential therapeutic strategies, particularly in the regulation of cell cycle and embryogenesis.